PROFESSIONAL EDITION

The largest community of pharma leaders

ARS Pharmaceuticals Announces the Appointment of Two New Board Members

SAN DIEGO–(BUSINESS WIRE)–ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions potentially leading to anaphylaxis, today announced the appointment of two new members to its Board of Directors – Michael Kelly, former president of U.S. operations for Adapt Pharma, and Phillip Schneider, board member and chairman of the audit committee for Pfenex Inc. and former chief financial offi…

 

 

http://www.businesswire.com/news/home/20190618005210/en/ARS-Pharmaceuticals-Announces-Appointment-New-Board-Members/

Recent Articles